000 01440 a2200385 4500
005 20250514165323.0
264 0 _c20040217
008 200402s 0 0 eng d
022 _a1080-6040
024 7 _a10.3201/eid0911.030317
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCasin, Isabelle
245 0 0 _aFluoroquinolone resistance linked to GyrA, GyrB, and ParC mutations in Salmonella enterica typhimurium isolates in humans.
_h[electronic resource]
260 _bEmerging infectious diseases
_cNov 2003
300 _a1455-7 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAged
650 0 4 _aAnti-Infective Agents
_xtherapeutic use
650 0 4 _aCiprofloxacin
_xtherapeutic use
650 0 4 _aDNA Gyrase
_xdrug effects
650 0 4 _aDrug Resistance, Multiple, Bacterial
_xgenetics
650 0 4 _aFluoroquinolones
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aInfant
650 0 4 _aMale
650 0 4 _aMicrobial Sensitivity Tests
650 0 4 _aSalmonella Infections
_xdrug therapy
650 0 4 _aSalmonella typhimurium
_xdrug effects
700 1 _aBreuil, Jacques
700 1 _aDarchis, Jean Pierre
700 1 _aGuelpa, Claire
700 1 _aCollatz, Ekkehard
773 0 _tEmerging infectious diseases
_gvol. 9
_gno. 11
_gp. 1455-7
856 4 0 _uhttps://doi.org/10.3201/eid0911.030317
_zAvailable from publisher's website
999 _c14446405
_d14446405